SCHEMBL5201137

SCHEMBL5201137

Cc1ccccc1C(Cl)=NN

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAOA P21397 1/20 0.39
MAOB P27338 1/20 0.39
NPC1 O15118 3/20 0.39
RAB9A P51151 3/20 0.39
ELANE P08246 1/20 0.38
TSHR P16473 1/20 0.38
ACHE P22303 1/20 0.38
MYC P01106 1/20 0.37
HPGD P15428 1/20 0.37
FLT1 P17948 1/20 0.37
FLT4 P35916 1/20 0.37
KDR P35968 1/20 0.37
ERCC5 P28715 1/20 0.36
FEN1 P39748 1/20 0.36
BCHE P06276 1/20 0.36
HTT P42858 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
POLB P06746 1/20 0.35
KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5201132 1.00 MAOA (0.39) MAOAMAOBNPC1RAB9AELANE
SCHEMBL406588 0.80 TSHR (0.39) MAOAMAOBNPC1RAB9ATSHR
SCHEMBL406589 0.80 TSHR (0.39) MAOAMAOBNPC1RAB9ATSHR
SCHEMBL31204265 0.80 TSHR (0.39) MAOAMAOBNPC1RAB9ATSHR
SCHEMBL11367447 0.76 CES2 (0.48) NPC1RAB9ATSHRHPGDERCC5
SCHEMBL23188035 0.76 RAB9A (0.47) MAOAMAOBNPC1RAB9ATSHR
SCHEMBL5262396 0.76 RAB9A (0.47) MAOAMAOBNPC1RAB9ATSHR
SCHEMBL28127812 0.76 NPC1 (0.40) MAOAMAOBNPC1RAB9ATSHR
SCHEMBL15354294 0.76 NPC1 (0.40) MAOAMAOBNPC1RAB9ATSHR
SCHEMBL5262402 0.76 RAB9A (0.47) MAOAMAOBNPC1RAB9ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1817292-A2 NOVEL HETEROCYCLE DERIVATIVES USEFUL AS SELECTIVE ANDROGEN RECEPTOR MODULATORS (SARMS) JANSSEN PHARMACEUTICA N.V. (BE) 2007-08-15 EP disclosed
WO-2006055184-A2 NOVEL HETEROCYCLE DERIVATIVES USEFUL AS SELECTIVE ANDROGEN RECEPTOR MODULATORS (SARMS) JANSSEN PHARMACEUTICA N.V. (BE) 2006-05-26 WO disclosed